comparemela.com

Latest Breaking News On - Yotin chinvarun - Page 1 : comparemela.com

Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress

CORAL GABLES, Fla., Aug. 14, 2023 Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel. -Today at 08:06 am- MarketScreener

Dublin
Ireland
United-states
Canada
America
Gary-ingenito
Pavel-vlasov
Yotin-chinvarun
Ricardo-sainz-fuertes
Claudio-liguori
Stella-ngo
Patricia-penovich

Eisai To Present Real-World Evidence And Convulsive Seizure Freedom Data Evaluating FYCOMPA® (perampanel) Across Patient Types At 75th American Epilepsy Society (AES) Annual Meeting

/PRNewswire/ Eisai Inc. announced today that new data on its antiepileptic drug FYCOMPA® (perampanel) CIII will be presented at the 75th American Epilepsy.

Yuji
Okinawa
Japan
Takaya
Akagawa
United-states
Hoshida
Osaka
Italy
Chicago
Illinois
Higashiyama

Eisai To Present Real-World Evidence And Convulsive Seizure Freedom Data Evaluating FYCOMPA® (perampanel) Across Patient Types At 75th American Epilepsy Society (AES) Annual Meeting

/PRNewswire/ Eisai Inc. announced today that new data on its antiepileptic drug FYCOMPA® (perampanel) CIII will be presented at the 75th American Epilepsy.

Yuji
Okinawa
Japan
Takaya
Akagawa
United-states
Hoshida
Osaka
Italy
Chicago
Illinois
Higashiyama

vimarsana © 2020. All Rights Reserved.